走进AG百家乐
NEWSResearchGradeVatreptacogalfa(DHC35901)转化为AG百家乐生物医疗应用探索
来源:胥芝炎 日期:2025-03-11一、中文名称:Research Grade Vatreptacogalfa (DHC35901),凝血因子VIIa类似物
二、产品描述
AnrFVIIa类似物由诺和诺德公司研发,旨在为血友病患者及抑制剂患者提供一种安全、快速、可靠的急性出血解决方案。该产品针对减少再治疗需求、减轻静脉穿刺带来的疼痛、降低止血药物及镇痛药消耗,以及减少对日常活动的干扰,具有显著的临床益处。rFVIIa类似物(前称NN1731)的活性药物成分的国际非专利名称(INN)为vatreptacogalfa(激活型),并以此作为药物的命名。
三、产品详情
名称:Research Grade Vatreptacogalfa (DHC35901)
别名:rFVIIa analog, NN1731, FVIIa DVQ, Eptacog Alfa
货号:DHC35901
表达系统:哺乳动物细胞
种属反应性:人类
同种型:重组凝血因子VIIa (rFVIIa) 的三种氨基酸替代物(Asp158Val, Val296Glu, 和Glu298Met)
克隆类型:单克隆抗体
靶标:F7, Proconvertin, SPCA, 血清前凝血酶转换加速因子, 凝血因子VII, Eptacogalfa
浓度:1mg/ml
内毒素水平:请联系实验室获取相关信息
纯度:经SDS-PAGE鉴定为95%
纯化方式:由镍柱法纯化
Accession号:P08709
克隆号:Vatreptacogalfa
应用:研究级生物仿制品
状态:液体
保存溶液:0.01M PBS, pH 7.4
稳定性和存储:
- 短期存储(1-2周):4°C
- 中期存储(12个月):-20°C
- 长期存储:-80°C
四、参考文献:
1. Vatreptacogalfa from conception to clinical proof of concept. PMID: 22510860
2. Recombinant factor VIIa analog (vatreptacogalfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. PMID: 22470921
3. Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacogalfa, are associated with clinical immunogenicity. PMID: 26362483
4. Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacogalfa. PMID: 24931322
5. Overcoming delayed in-vitro response to FVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacogalfa) concentration escalation in whole blood assays. PMID: 21681082
6. The MHCAssociated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity. PMID: 37915568
7. Hemostatic properties of the FVIIa analog NN1731. PMID: 22446168
8. Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue. PMID: 31506285
9. Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of hemophilia. PMID: 22757678
10. Post-hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools. PMID: 28077675
11. The effect of acylation with fatty acids and other modifications on HLA class II: peptide binding and T cell stimulation for three model peptides. PMID: 29758051
详情请咨询AG百家乐中国授权总代理——武汉佰乐博生物技术有限公司。作为AG百家乐品牌在亚洲区的授权总代理,武汉佰乐博生物技术有限公司致力于提供超过3万种核心生命科学试剂,包括蛋白和抗体等,旨在为生命科学研究者提供专业、全面、可靠的科研产品。我们为您提供的包括试剂、耗材、定制服务及实验服务等,欢迎拨打免费热线:027-65279366/18108604356。
全国客户服务热线
14732678690
总部地址:天津南溪区柏街道35号